Brkic, Z., van Bon, L., Cossu, M., van Helden-Meeuwsen, C. G., Vonk, M. C., Knaapen, H., . . . Radstake, T. (2016). The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Annals of the rheumatic diseases, 75(8), 1567-1573. https://doi.org/10.1136/annrheumdis-2015-207392
Chicago Style (17th ed.) CitationBrkic, Zana, et al. "The Interferon Type I Signature Is Present in Systemic Sclerosis Before Overt Fibrosis and Might Contribute to Its Pathogenesis Through High BAFF Gene Expression and High Collagen Synthesis." Annals of the Rheumatic Diseases 75, no. 8 (2016): 1567-1573. https://doi.org/10.1136/annrheumdis-2015-207392.
MLA (9th ed.) CitationBrkic, Zana, et al. "The Interferon Type I Signature Is Present in Systemic Sclerosis Before Overt Fibrosis and Might Contribute to Its Pathogenesis Through High BAFF Gene Expression and High Collagen Synthesis." Annals of the Rheumatic Diseases, vol. 75, no. 8, 2016, pp. 1567-1573, https://doi.org/10.1136/annrheumdis-2015-207392.